Drug Type Molecular glue |
Synonyms ASHA 044, ASHA044 |
Target |
Action stimulants |
Mechanism CTNNB1 stimulators(Catenin beta 1 stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Preclinical | United States | 20 Oct 2023 | |
| Hepatocellular Carcinoma | Preclinical | United States | 20 Oct 2023 |





